Presentation Information
[O1-02]Safety and effectiveness of nipocalimab in adolescent participant in the open label phase 2/3 VIBRANCE-MG clinical study
○Keiko Ishigaki1, Akiyuki Uzawa2, Yasuhiro Kimoto3, Jonathan Strober4, Saunder Bernes5, Tuan Vu6, Shawn Black7, Sindhu Ramchandren7, Dan Huang8, Yaowei Zhu7, Hong Sun7 (1.Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan, 2.Department of Neurology, Chiba University Hospital, Chiba, Japan, 3.Department of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan, 4.UCSF Benioff Children’s Hospital San Francisco, 5.Phoenix Children’s Hospital, 6.University of South Florida, 7.Janssen Research & Development, LLC, 8.Janssen Research & Development, Janssen‒Cilag GmbH)